AVE 0.00% 0.3¢ avecho biotechnology limited

abc to feature poh on landline, page-3

  1. 5,322 Posts.
    Playez you'll also get your TPM science peer review wishlist ticked off when USDA publishes Mastitis trial results in various Science mags. This Mastitis product is getting some very good traction for POH eh?

    Talk of small royalties in the animal health area needs to be balanced by the magnitude of the market value for such a product ...and the fact that this Mastitis product will require by far the largest production of raw TPM material ...the volume of raw TPM required for a successful Mastitis product is bigger than any other pipeline POH project by many times . Thus Mastitis could be worth more to POH than OxyC- the revenue of royalties and raw TPM sales is mindboggling.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.508M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $7.098K 2.788M

Buyers (Bids)

No. Vol. Price($)
48 95299175 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20889253 12
View Market Depth
Last trade - 15.43pm 20/06/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.